In the course of COVID–19 disease, hypoxia, inflammatory mediators, thrombocythemia, immobilization, sepsis, liver injury secondary to ACE2 receptor expression may predispose to arterial and venous thrombosis. [5,6] Microthrombi and inflammatory mediators are postulated to cause mesenteric ischemia as COVID 19 is said to cause endothelial damage. Patients with severe COVID–19 complicated by AMI may present with abdominal pain, nausea/vomiting, diarrhoea, abdominal distention or worsening systemic status (sepsis).
Many case reports worldwide have shown high morbidity and mortality when COVID 19 and mesenteric arterial thrombosis occur together usually leading to large bowel resections and death. Usually COVID 19 treating physicians have more focus towards occurrence of lower respiratory tract symptoms and may neglect bowel symptoms which tend to be more urgent to manage. Once organ failure sets in, the scenario ends up more frequently as a vicious cycle.
Our patient primarily came with severe abdominal pain not responding to medications and high fever which made us more suspicious for COVID 19. Early CT Angiogram of the abdomen gave us the diagnosis of Acute Superior Mesenteric Artery Thrombosis with jejunal thrash and impending gangrene of bowel. Early diagnosis and efficient thrombolysis resulted in better bowel salvage with complete resolution of symptoms on Post operative Day 1 with patient starting oral intake from Post operative Day 3.
Early management of arterial thrombosis compromising blood flow even with COVID 19 can help in reducing morbidity of COVID 19 and thus reduce overall mortality rates even while we remain trapped in the web of this PANDEMIC!!!